Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study.

Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M, Marsch S, Azzola A, Rakic J, Mueller B, Tamm M.

Eur Respir J. 2009 Dec;34(6):1364-75. doi: 10.1183/09031936.00053209. Epub 2009 Sep 24.

2.

Value of the serum procalcitonin level to guide antimicrobial therapy for patients with ventilator-associated pneumonia.

Luyt CE, Combes A, Trouillet JL, Chastre J.

Semin Respir Crit Care Med. 2011 Apr;32(2):181-7. doi: 10.1055/s-0031-1275530. Epub 2011 Apr 19. Review.

PMID:
21506054
3.

Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.

Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Müller B.

Am J Respir Crit Care Med. 2006 Jul 1;174(1):84-93. Epub 2006 Apr 7.

PMID:
16603606
4.

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M; PRORATA trial group.

Lancet. 2010 Feb 6;375(9713):463-74. doi: 10.1016/S0140-6736(09)61879-1. Epub 2010 Jan 25.

PMID:
20097417
5.

Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.

Pugh R, Grant C, Cooke RP, Dempsey G.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007577. doi: 10.1002/14651858.CD007577.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;8:CD007577.

PMID:
21975771
6.

Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.

Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C, Widmer I, Neidert S, Blum CA, Schönenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Müller B; ProHOSP study group.

BMC Health Serv Res. 2007 Jul 5;7:102.

7.

Procalcitonin-guided antibiotic therapy in aspiration pneumonia and an assessment of the continuation of oral intake.

Ogasawara T, Umezawa H, Naito Y, Takeuchi T, Kato S, Yano T, Kasamatsu N, Hashizume I.

Respir Investig. 2014 Mar;52(2):107-13. doi: 10.1016/j.resinv.2013.08.002. Epub 2013 Sep 26.

PMID:
24636266
8.

Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients.

Layios N, Lambermont B, Canivet JL, Morimont P, Preiser JC, Garweg C, Ledoux D, Frippiat F, Piret S, Giot JB, Wiesen P, Meuris C, Massion P, Leonard P, Nys M, Lancellotti P, Chapelle JP, Damas P.

Crit Care Med. 2012 Aug;40(8):2304-9. doi: 10.1097/CCM.0b013e318251517a.

PMID:
22809906
9.

Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score.

Jung B, Embriaco N, Roux F, Forel JM, Demory D, Allardet-Servent J, Jaber S, La Scola B, Papazian L.

Intensive Care Med. 2010 May;36(5):790-8. doi: 10.1007/s00134-010-1833-5. Epub 2010 Mar 9.

PMID:
20217042
10.

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B; ProHOSP Study Group.

JAMA. 2009 Sep 9;302(10):1059-66. doi: 10.1001/jama.2009.1297.

PMID:
19738090
11.

[Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study].

Fekih Hassen M, Ayed S, Ben Sik Ali H, Gharbi R, Marghli S, Elatrous S.

Ann Fr Anesth Reanim. 2009 Jan;28(1):16-23. doi: 10.1016/j.annfar.2008.10.021. Epub 2008 Dec 18. French.

PMID:
19097848
12.

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, Kemperman H, van den Elsen MJ, Schouten JA, Streefkerk JO, Krabbe HG, Kieft H, Kluge GH, van Dam VC, van Pelt J, Bormans L, Otten MB, Reidinga AC, Endeman H, Twisk JW, van de Garde EMW, de Smet AMGA, Kesecioglu J, Girbes AR, Nijsten MW, de Lange DW.

Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2.

PMID:
26947523
13.

Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.

Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Müller C, Huber P, Müller B, Tamm M.

Chest. 2007 Jan;131(1):9-19.

PMID:
17218551
14.

Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia.

Luyt CE, Combes A, Reynaud C, Hekimian G, Nieszkowska A, Tonnellier M, Aubry A, Trouillet JL, Bernard M, Chastre J.

Intensive Care Med. 2008 Aug;34(8):1434-40. doi: 10.1007/s00134-008-1112-x. Epub 2008 Apr 18.

PMID:
18421435
15.

Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation.

Wang L, Li X, Yang Z, Tang X, Yuan Q, Deng L, Sun X.

Cochrane Database Syst Rev. 2016 Jan 8;(1):CD009946. doi: 10.1002/14651858.CD009946.pub2. Review.

PMID:
26743945
16.

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Müller B.

Lancet. 2004 Feb 21;363(9409):600-7.

PMID:
14987884
17.

Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.

Pugh R, Grant C, Cooke RP, Dempsey G.

Cochrane Database Syst Rev. 2015 Aug 24;(8):CD007577. doi: 10.1002/14651858.CD007577.pub3. Review.

PMID:
26301604
18.

Individualized antibiotic therapy in patients with ventilator-associated pneumonia.

Yilmaz G, Salyan S, Aksoy F, Köksal İ.

J Med Microbiol. 2017 Jan;66(1):78-82. doi: 10.1099/jmm.0.000401. Epub 2017 Feb 22.

PMID:
27911257
19.

Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.

Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr TT, Andersen MH, Thornberg KJ, Løken J, Steensen M, Fox Z, Tousi H, Søe-Jensen P, Lauritsen AØ, Strange D, Petersen PL, Reiter N, Hestad S, Thormar K, Fjeldborg P, Larsen KM, Drenck NE, Ostergaard C, Kjær J, Grarup J, Lundgren JD; Procalcitonin And Survival Study (PASS) Group.

Crit Care Med. 2011 Sep;39(9):2048-58. doi: 10.1097/CCM.0b013e31821e8791.

PMID:
21572328
20.

Changes in serum procalcitonin and C-reactive protein following antimicrobial therapy as a guide to antibiotic duration in the critically ill: a prospective evaluation.

Venkatesh B, Kennedy P, Kruger PS, Looke D, Jones M, Hall J, Barruel GR.

Anaesth Intensive Care. 2009 Jan;37(1):20-6.

Supplemental Content

Support Center